Alberta Investment Management Corp Biogen Inc. Transaction History

Alberta Investment Management Corp

$8.3 Billion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $445,242 - $562,191	-2,100 Reduced 31.82%	4,500 $970,000
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $467,439 - $562,674	2,100 Added 46.67%	6,600 $1.71 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $3.82 Million - $4.41 Million	-13,879 Reduced 75.52%	4,500 $1.28 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $7.03 Million - $8.01 Million	-27,400 Reduced 59.85%	18,379 $5.11 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $4.04 Million - $4.91 Million	-16,006 Reduced 25.91%	45,779 $12.7 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $7.63 Million - $10.5 Million	39,170 Added 173.2%	61,785 $16.5 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $3.62 Million - $4.31 Million	19,315 Added 585.3%	22,615 $4.61 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $9.67 Million - $12.2 Million	-49,900 Reduced 93.8%	3,300 $695,000
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $7.05 Million - $9.06 Million	31,500 Added 145.16%	53,200 $12.8 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $4.84 Million - $6.31 Million	17,100 Added 371.74%	21,700 $6.14 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $284,900 - $456,181	1,100 Added 31.43%	4,600 $1.59 Million
Q1 2021 May 07, 2021	SELL	$242.95 - $284.63 $9.84 Million - $11.5 Million	-40,500 Reduced 92.05%	3,500 $979,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $1.56 Million - $2.35 Million	6,600 Added 17.65%	44,000 $10.8 Million
Q3 2020 Oct 26, 2020	SELL	$264.77 - $305.71 $8.71 Million - $10.1 Million	-32,900 Reduced 46.8%	37,400 $10.6 Million
Q2 2020 Aug 11, 2020	BUY	$258.66 - $342.55 $2.04 Million - $2.71 Million	7,900 Added 12.66%	70,300 $18.8 Million
Q1 2020 May 08, 2020	SELL	$268.85 - $341.04 $43 Million - $54.5 Million	-159,900 Reduced 71.93%	62,400 $19.7 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $8.65 Million - $11.9 Million	39,300 Added 21.48%	222,300 $66 Million
Q3 2019 Oct 23, 2019	BUY	$217.44 - $243.88 $16.9 Million - $18.9 Million	77,700 Added 73.79%	183,000 $42.6 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $197,361 - $217,548	900 Added 0.86%	105,300 $24.6 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $4.03 Million - $6.3 Million	18,600 Added 21.68%	104,400 $24.7 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $3.59 Million - $4.55 Million	-12,900 Reduced 13.07%	85,800 $25.8 Million
Q3 2018 Nov 16, 2018	BUY	$293.51 - $383.83 $18.1 Million - $23.6 Million	61,500 Added 165.32%	98,700 $34.9 Million
Q2 2018 Aug 15, 2018	SELL	$257.52 - $306.91 $18.5 Million - $22 Million	-71,800 Reduced 65.87%	37,200 $10.8 Million
Q1 2018 May 16, 2018	BUY	$260.13 - $367.91 $5.25 Million - $7.43 Million	20,200 Added 22.75%	109,000 $29.8 Million
Q4 2017 Feb 15, 2018	SELL	$307.64 - $344.58 $123,056 - $137,832	-400 Reduced 0.45%	88,800 $28.3 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $25.1 Million - $29.4 Million	89,200	89,200 $27.9 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Account